Peter M Hecht, an insider of Cyclerion Therapeutics, Inc., recently acquired 823,170 shares of the company. The buys took place at $3.28 per share, on June 03, 2021. Hecht now owns 2,049,153 shares of the company. Hecht operates out of Cambridge, MA. Some additional info was provided as follows:
On June 3, 2021, the reporting person agreed to purchase directly from the Issuer 823,170 shares of Common Stock of the Issuer in a private placement transaction.
These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Cyclerion Therapeutics, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Current report, items 7.01 and 9.01
- Sept. 30, 2021